Repurposing of PSMA-targeted diagnostic and therapeutic agents for the detection and treatment of giant cell tumors of bone is a research paper published in Frontiers in Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: P30 CA047904
NIDCR NIH HHS
Grant: T90 DE033006
NIDDK NIH HHS
Grant: F31 DK081307
NIA NIH HHS
Grant: R01 AG012376
NCI NIH HHS
Grant: R21 CA282396
NCI NIH HHS
Grant: K01 CA188412
NCI NIH HHS
Grant: R21 CA256382
National Institutes of Health
Grant: 1R21CA256382-01
Near-IR Ratiometric Fluorescence Probes for Assessing Cargo Delivery to Prostate Tumors
National Institutes of Health
Grant: 1R21CA282396-01A1
Frontiers in Bone Metastatic Models for Prostate Cancer
National Institutes of Health
Grant: 1T90DE033006-01
Skeletal, Craniofacial and Oral Biology Training Grant
FWCI
1.91
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals